Graphene has extreme conductivity and is completely transparent while being inexpensive and nontoxic. This makes it a perfect candidate material for transparent contact layers for use in solar cells to conduct electricity without reducing the amount of incoming light - at least in theory. Whether or not this holds true in a real world setting is questionable as there is no such thing as "ideal" graphene - a free floating, flat honeycomb structure consisting of a single layer of carbon atoms: interactions with adjacent layers can change graphene's properties dramatically. Now, Dr. Marc Gluba and Prof. Dr. Norbert Nickel of the HZB Institute for Silicon Photovoltaics have shown that graphene retains its impressive set of properties when it is coated with a thin silicon film. These findings have paved the way for entirely new possibilities to use in thin-film photovoltaics.
Patient generated data could be the future of healthcare and the solution to time consuming data entry
Electronic Health Records (EHRs) and computerized technology have been leveraged in hopes of increasing quality of care while decreasing costs, but what is to be done with the wealth of patient generated data (PGD) that has been mined in the process?
According to InformationWeek Healthcare, “Any health or medical data a patient inputs electronically is considered patient-generated data. PGD emanates from a wide spectrum of technology, from wellness apps to at-home tests for clinical diagnoses.
Even consumer activity-tracking devices such as Fitbit and Nike FuelBand could become sources of PGD.
“The healthcare industry needs to undergo a cultural shift that emphasizes customer satisfaction and patient interaction more. In industries such as retail or automotive, customer-centric technology is not only expected, but required. Think of Amazon's customer service reputation. That level of service has become the customer standard and the healthcare industry is starting to heed this standard.”
"In many environments, the patient is the best source of data for how they're doing in their own disease," said Ben Heywood, co-founder and president of PatientsLikeMe. "The health system in general is beginning to understand the importance of patient reported outcomes, but that isn't integrated into standard decision frameworks yet."
John Halamka, CIO of Beth Israel Deaconess Medical Center in Boston said, “The next days of our work will be patient-generated data. We'll have EHR data, cost and quality metrics, and patient data. It's not only looking continuously from the outside, but assessing care from the patient's perspective."
Data sharing is just the beginning though; patient portals that allow patients to not only view their records but also correct and update them are an excellent indication of the potential of PGD. Most of the PGD that’s currently being generated is through patient portals, which are also part of Meaningful Use requirements. Encouraging patients to access these portals is now not just about meeting those MU requirements; it’s about a provider’s bottom line.
beyondbrics, from the Financial Times, brings news and comment from more than 40 emerging economies, headed by China, India, Brazil, Russia, Mexico, Indonesia and South Africa. We cover politics and economics, ...
The costs of drug development and prescription drugs are skyrocketing. Is digital health the key to controlling drug costs?
The key to reducing drug costs, then, is to reduce failure rates or, failing that, to fail faster, before all those cost inputs add up. It’s far better to identify a drug that will not succeed before that drug enters the costliest phases of the process.
Without a crystal ball, how can drug companies reduce the cost of development as it relates to failure/success rates?
The introduction of the sequenced genome suggested that this new innovation and the resulting data generated would provide a treasure of knowledge of how diseases worked, resulting in less costly ways to create drugs. To an extent the discovery and development process has become more efficient, but the reality clearly isn’t playing out as fast as the vision.
Assuming the pharmaceutical industry will not experience any revolutionary changes in the way it’s financed, as an industry its cost of capital will remain relatively constant. As long as drug development costs remain at their current levels, the prices charged for new drugs will have nowhere to go but up. So, where does the answer to high drug prices lie?
It may lie in the tremendous convergence of technologies occurring in the life sciences. Taken together, the effects of sequencing the genome and other life sciences discoveries, and adding digital health, the modern internet, and big data, can yield new approaches, new disciplines, and new technologies being brought to bear on the many problems and challenges faced by drug developers.
Dan Peterson, architect who advocated moving post office, dies Santa Rosa Press Democrat Santa Rosa's classic, Roman-columned 1910 post office faced demolition 40 years ago when architect Dan Peterson advocated saving it by picking it up and...
Here Comes the Sun: Global Warming and the Perversion of Science American Thinker As the hypothesis of man-caused global warming is trundled off to the Morgue for Scientific Hoaxes, let's anticipate the autopsy's preliminary findings: the subject...
Question Everything's insight:
Funny how the people in control of the Studies and research into global warming and its main campaigners were from the americans! I've always under-estimated the validity of Global warming
Learning Ace is a 100% student-focused web destination that leverages our proprietary adaptive search and recommendation technologies and our instructor/publisher relationships to develop an insanely valuable resource to students at each learning point of their coursework. Discover, Browse and Learn.
Sharing your scoops to your social media accounts is a must to distribute your curated content. Not only will it drive traffic and leads through your content, but it will help show your expertise with your followers.
How to integrate my topics' content to my website?
Integrating your curated content to your website or blog will allow you to increase your website visitors’ engagement, boost SEO and acquire new visitors. By redirecting your social media traffic to your website, Scoop.it will also help you generate more qualified traffic and leads from your curation work.
Distributing your curated content through a newsletter is a great way to nurture and engage your email subscribers will developing your traffic and visibility.
Creating engaging newsletters with your curated content is really easy.